Korro Bio Chief Scientific Officer Steve Colletti to resign effective August 2, 2024

Korro Bio, Inc.

Steve Colletti, Ph.D., notified Korro Bio of his resignation as Chief Scientific Officer on June 17, 2024.
His resignation is effective August 2, 2024.
Korro Bio is a biotechnology company focused on RNA editing, traded on Nasdaq under ticker KRRO.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Steve Colletti

Chief Scientific Officer

KRRO · Korro Bio, Inc.

Effective: 2024-08-02
Filed: June 21, 2024, 7:59 PM ET

On June 17, 2024, Steve Colletti, Ph.D., notified Korro Bio, Inc. of his intent to resign as its Chief Scientific Officer effective August 2, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Steve Colletti resigned as Chief Scientific Officer at Korro Bio, Inc..

Action: resigned
Role: Chief Scientific Officer

Exact text from the filing

On June 17, 2024, Steve Colletti, Ph.D., notified Korro Bio, Inc. of his intent to resign as its Chief Scientific Officer effective August 2, 2024.

View on SEC.gov

Korro Bio, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-165684

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.